The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125468582 12546858 2 F 20160609 20160810 20160711 20160812 EXP FR-009507513-1607FRA003466 MERCK 82.13 YR M Y 0.00000 20160812 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125468582 12546858 1 PS JANUVIA SITAGLIPTIN PHOSPHATE 1 Oral 100 MG (1 DF), PER DAY U 21995 100 MG FILM-COATED TABLET QD
125468582 12546858 2 SS XTANDI ENZALUTAMIDE 1 Oral 160 MG, UNK U 0 160 MG
125468582 12546858 3 SS CASODEX BICALUTAMIDE 1 Oral 50 MG (1 DF), PER DAY U 0 50 MG COATED TABLET QD
125468582 12546858 4 SS lactulose mylan LACTULOSE 1 Oral 2 DF, PER DAY U 0 2 DF QD
125468582 12546858 5 SS OXYNORMORO OXYCODONE 1 Oral IF NEEDED U 0 ORODISPERSIBLE TABLET
125468582 12546858 6 SS BISOPROLOL EG BISOPROLOL 1 Oral 1.25 MG, PER DAY U 0 QD
125468582 12546858 7 SS nicorandil biogaran NICORANDIL 1 Oral 20 MG (1 DF), PER DAY U 0 20 MG TABLET QD
125468582 12546858 8 SS KARDEGIC ASPIRIN LYSINE 1 Oral 75 MG (1 DF), PER DAY, IN SACHET U 0 75 MG POWDER FOR ORAL SOLUTION QD
125468582 12546858 9 SS DIFFU-K POTASSIUM CHLORIDE 1 Oral 1 DF, PER DAY 10 DF U 0 1 DF QD
125468582 12546858 10 SS esomeprazole EG ESOMEPRAZOLE 1 Oral 1 DF, PER DAY U 0 1 DF QD
125468582 12546858 11 SS prednisone mylan PREDNISONE 1 Oral 1 MG, PER DAY U 0 1 MG QD
125468582 12546858 12 SS pravastatin EG PRAVASTATIN SODIUM 1 Oral 20 MG (1 DF), PER DAY U 0 20 MG FILM-COATED TABLET QD
125468582 12546858 13 SS DOLIPRANE ACETAMINOPHEN 1 Oral 1 G, IF NEEDED U U 0 1 G
125468582 12546858 14 SS NORMACOL KARAYA GUM 1 Rectal IF NEEDED U U 0
125468582 12546858 15 SS OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 10 MG, 2 PER DAY U U 0 10 MG PROLONGED-RELEASE TABLET BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125468582 12546858 1 Diabetes mellitus
125468582 12546858 2 Prostate cancer
125468582 12546858 3 Prostate cancer
125468582 12546858 4 Constipation
125468582 12546858 5 Pain
125468582 12546858 6 Hypertension
125468582 12546858 7 Angina unstable
125468582 12546858 8 Cardiovascular event prophylaxis
125468582 12546858 9 Hypokalaemia
125468582 12546858 10 Gastrooesophageal reflux disease
125468582 12546858 11 Product used for unknown indication
125468582 12546858 12 Hypercholesterolaemia
125468582 12546858 13 Pain
125468582 12546858 14 Constipation
125468582 12546858 15 Pain

Outcome of event

Event ID CASEID OUTC COD
125468582 12546858 DE
125468582 12546858 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125468582 12546858 Hepatic function abnormal

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125468582 12546858 1 20160606 0
125468582 12546858 2 20160524 0
125468582 12546858 3 20160210 0
125468582 12546858 4 20160528 0
125468582 12546858 5 20160526 0
125468582 12546858 6 20151127 0
125468582 12546858 9 20160528 20160606 0
125468582 12546858 10 20160606 0
125468582 12546858 11 20160606 0
125468582 12546858 12 20160606 0
125468582 12546858 14 20160507 0
125468582 12546858 15 20160526 0